Drawing for ALLERGAN

USPTO serial 73050514

ALLERGAN

Reviewed by CopyMark Law Group

Reg. 1041583Status 900
Filing date
Status date
Registration date
Jun 22, 1976
Examiner
—
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALLERGAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003OPTHALMIC AND OPTICAL FORMULATIONS-NAMELY, FORMULATIONS FOR THE CARE OF CONTACT LENSES-NAMELY, CONTACT LENS CLEANING SOLUTIONS, CONTACT LENS CLEANING AND SOAKING SOLUTIONS, CONTACT LENS CUSHIONING SOLUTION; DERMATOLOGICAL FORMULATIONS-NAMELY, DRY SKIN LOTION, DRY SKIN CREAM, MEDICATED DANDRUFF SHAMPOO, LOTION FOR PREVENTION OF SUNBURNEXPIREDJan 20, 1950
005OPTHALMIC FORMULATIONS, SPECIFICALLY ANTI-INFLAMMATORY FORMULATIONS, ANTI-INFLAMMATORY/ANTI-INFECTIVE FORMULATIONS, ANTI-INFECTIVE FORMULATIONS, ANTI-GLAUCOMA FORMULATIONS, STERILE OINTMENTS, DECONGESTANT FORMULATIONS, DECONGESTANT/ANTIHISTAMINE FORMULARIONS, WETTING SOLUTIONS, FORMULATIONS FOR MINOR OCULAR INFLAMMATORY AND ALLERGIC CONDITIONS, ARTIFICIAL TEARS; CONTAINERS FOR STORAGE AND CARE OF CONTACT LENSES; DERMATOLOGICAL FORMULATIONS NAMELY, MEDICATED SOLUTION FOR TREATMENT OF ACTINIC KERATOSIS, MEDICATED AEROSOL FOR TREATMENT OF SEBORRHEA, MEDICATED DRY SKIN LOTION, MEDICATED DRY SKIN CREAMEXPIREDJan 20, 1950

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 31, 1997EXRGEXPIRED SEC. 9—
Feb 9, 1982C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—

Frequently asked questions

Related guidance